Skip to main content
. 2012 Feb;3(Suppl 1):39–46. doi: 10.1055/s-0031-1298607

Table 2. Adjacent segment disease.

Outcomes Strength of evidence Conclusions/comments
1. ASD – symptomatic graphic file with name ebsj03039-004.jpg
  • No statistical differences between treatment groups noted across three CoE II RCTs and one cohort (CoE III) study.

  • Given the low rates of ASD across studies, one might question whether studies were sufficiently powered to assess this outcome

2. ASD – radiographic graphic file with name ebsj03039-005.jpg
  • No statistical differences between treatment groups noted across one CoE II RCT and four CoE III cohort studies.

  • The relationship between radiographic and symptomatic ASD is not clear. Radiographic ASD may be an intermediate outcome, and no directional relationship between radiographic and symptomatic ASD was evaluated.

3. Timing of ASD graphic file with name ebsj03039-005.jpg
  • No statistical differences between treatment groups noted across two cohort studies.

4. Range of motion at adjacent segments graphic file with name ebsj03039-005.jpg
  • No statistical differences between treatment groups noted across two RCT analyses